Douwe Postmus

6PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersEpidemiological methodsEconometric and statistical methodsHaematological tumoursOrganisational, interpersonal and intercultural communication
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 11, 2026
Association of CT-assessed sarcopenia and the development of immune-related adverse events and overall survival: a multistate survival analysis.

Erick Suazo-Zepeda, Marjolein A Heuvelmans, Douwe Postmus

|Feb 11, 2026
Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real-World Data.

Francesco Pignatti, Tarec Christoffer El-Galaly, Martin Kaiser

|May 13, 2025
Expedited Approval in Oncology: A Study of European Regulators' Perspectives and Trade-Offs.

Francesco Pignatti, Filip Josephson, Pierre Demolis

|Apr 29, 2024
Benefits and risks of clofarabine in adult acute lymphoblastic leukemia investigated in depth by multi-state modeling.

Sjoerd J F Hermans, Yvette van Norden, Jurjen Versluis

|Feb 15, 2023
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.

Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries

|Sep 27, 2022
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicines.

Douwe Postmus, Francesco Pignatti, Hans L Hillege

Pageof 1

Frequent Collaborators

3 joint publications

Francesco Pignatti

2 joint publications

Peter Mol

1 joint publications

Sonia Roldan Munoz

1 joint publications

Sieta T de Vries